Market Challenges And Opportunities

Global Glycated Albumin Assay Market- Driver

Increasing research and development activity by key players in the market

The glycated albumin assay is used in research and development for the diagnosis of diabetes. Thus, increasing research related to glycated albumin assay, by key players in the market is expected to drive the market growth over the forecast period. For instance, in June 2022, Frontiers Media, which is an open source scientific journal, published an article stating the use of glycated albumin to define partial remission in type 1 diabetes.

Increasing prevalence of diabetes

The glycated albumin assay technology is used for the diagnosis of diabetes, and thus, the increasing prevalence of diabetes is expected to drive the market growth over the forecast period. For instance, in October 2021, a report published on National Center for Biotechnology Information (NCBI), stated that the prevalence of diabetes in India has risen from 7.1% in 2009 to 8.9% in 2019.

Global Glycated Albumin Assay Market: Restraint

Launch of glycated hemoglobin assay for diagnosing diabetes mellitus

The major factor that can hamper the growth of the global glycated albumin assay market over the forecast period is the launch of glycated hemoglobin assay for the diagnosis of diabetes. For instance, in June 2021, Afinion HbA1c Dx assay was developed by got approved by the U.S. Food and Drug Administration for point-of-care test.

Restraints & Challenges: